ABOUT

Immunophage is a clinical-stage biotech company focusing on discovering, developing, and commercializing innovative drugs globally for patients worldwide. The company strengthens its R&D pipeline by continually exploring novel disease pathophysiology, refining new targets, and discovering small-molecule or large-molecule drugs. Immunophage aims to advance two innovative programs into clinical trials every year by combining internal R&D expertise and partnerships with global biopharmaceutical companies.

  • 2016
    Establishment of the
    company
  • 5
    Number of subsidiaries
    established
  • 3
    Involved in research
    field
  • 70
    %
    More than 70% of R&D personnel with
    master's degree or above
OUR VISION
An integrated global R&D biopharma to discover and develop innovative
medicines for patients worldwide
OUR MISSION
To discover first-in-class drugs to treat major diseases such as cancers,
autoimmune and neurodegenerative diseases,with unmet medical needs.
CORE VALUES

Collaboration

Innovation

Passion

Integrity

Prudence

TEAM